These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9641893)

  • 1. Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?
    Hotz HG; Runkel NS; Frank-Raue K; Raue F; Buhr HJ
    Langenbecks Arch Surg; 1998 Apr; 383(2):170-3. PubMed ID: 9641893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening].
    Röher HD; Simon D; Goretzki PE; Höppner W; Lederbogen S; Seppel T
    Chirurg; 1995 Dec; 66(12):1196-202. PubMed ID: 8582162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC).
    Niccoli-Sire P; Murat A; Baudin E; Henry JF; Proye C; Bigorgne JC; Bstandig B; Modigliani E; Morange S; Schlumberger M; Conte-Devolx B
    Eur J Endocrinol; 1999 Nov; 141(5):468-74. PubMed ID: 10576762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
    J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
    Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre.
    Piolat C; Dyon JF; Sturm N; Pinson S; Bost M; Jouk PS; Plantaz D; Chabre O
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):118-24. PubMed ID: 16817830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.
    Dralle H; Gimm O; Simon D; Frank-Raue K; Görtz G; Niederle B; Wahl RA; Koch B; Walgenbach S; Hampel R; Ritter MM; Spelsberg F; Heiss A; Hinze R; Höppner W
    World J Surg; 1998 Jul; 22(7):744-50; discussion 750-1. PubMed ID: 9606292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
    Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P
    J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
    Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
    ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of prophylactic thyroidectomy in pediatric multiple endocrine neoplasia 2: a nationwide survey in Japan 1997-2017.
    Matsushita R; Nagasaki K; Ayabe T; Miyoshi Y; Kinjo S; Haruna H; Ihara K; Hasegawa T; Ida S; Ozono K; Minamitani K;
    J Pediatr Endocrinol Metab; 2019 Jun; 32(6):585-595. PubMed ID: 31150358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.